Sulfoquinovosylacylpropanediol monotherapy suppresses canine hemangiosarcoma patient-derived xenograft models with vascular remodeling
Keisuke Aoshima, Natsuki Miyazaki, Takuma Goto, Kazuki Heishima
This study shows that SQAP reduces tumor growth in canine HSA PDX models by altering vascular and macrophage-related tumor microenvironment features, not through direct cytotoxicity.
bioRxiv · Jul 5, 2026 · PreprintCancer Biology